UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 35

Sortiert nach

Pharmacological characterization of AM1710, a putative cannabinoid CB2 agonist from the cannabilactone class: Antinociception without central nervous system side-effects

Pharmacology, biochemistry and behavior, 2011-06, Vol.98 (4), p.493-502

2011

Link zum Volltext

Verfügbarkeit prüfen

The novel cannabinoid CB1 receptor neutral antagonist AM4113 suppresses food intake and food-reinforced behavior but does not induce signs of nausea in rats

Neuropsychopharmacology (New York, N.Y.), 2008-03, Vol.33 (4), p.946-955

2008

Link zum Volltext

Verfügbarkeit prüfen

Endocannabinoids Are Expressed in Bone Marrow Stromal Niches and Play a Role in Interactions of Hematopoietic Stem and Progenitor Cells with the Bone Marrow Microenvironment

The Journal of biological chemistry, 2010-11, Vol.285 (46), p.35471-35478

2010

Link zum Volltext

Verfügbarkeit prüfen

The Novel Cannabinoid CB1 Receptor Neutral Antagonist Am4113 Suppresses Food Intake and Food-Reinforced Behavior but Does not Induce Signs of Nausea in Rats

Neuropsychopharmacology (New York, N.Y.), 2008-06, Vol.33 (7), p.1776

2008

Link zum Volltext

Verfügbarkeit prüfen

Inhibition of N-acylethanolamine acid amidase reduces nicotine-induced dopamine activation and reward

Neuropharmacology, 2019-01, Vol.144, p.327-336

2019

Link zum Volltext

Verfügbarkeit prüfen

Improved cyclobutyl nabilone analogs as potent CB1 receptor agonists

European journal of medicinal chemistry, 2022-02, Vol.230, p.114027-114027, Article 114027

2022

Link zum Volltext

Verfügbarkeit prüfen

Dietary docosahexaenoic acid supplementation alters select physiological endocannabinoid-system metabolites in brain and plasma

Journal of lipid research, 2010-06, Vol.51 (6), p.1416-1423

2010

Link zum Volltext

Verfügbarkeit prüfen

Piperidine and piperazine inhibitors of fatty acid amide hydrolase targeting excitotoxic pathology

Bioorganic & medicinal chemistry, 2019-12, Vol.27 (23), p.115096-115096, Article 115096

2019

Link zum Volltext

Verfügbarkeit prüfen

Maternal Dietary Fatty Acids and Their Relationship to Derived Endocannabinoids in Human Milk

Journal of human lactation, 2021-11, Vol.37 (4), p.813-820

2021

Link zum Volltext

Verfügbarkeit prüfen

Oximes short-acting CB1 receptor agonists

Bioorganic & medicinal chemistry, 2018-10, Vol.26 (18), p.4963-4970

2018

Link zum Volltext

Verfügbarkeit prüfen

Pharmacological characterization of AM1710, a putative cannabinoid CB 2 agonist from the cannabilactone class: Antinociception without central nervous system side-effects

Pharmacology, biochemistry and behavior, 2011-06, Vol.98 (4), p.493-502

2011

Link zum Volltext

Verfügbarkeit prüfen

Endocannabinoid and cannabinoid-like fatty acid amide levels correlate with pain-related symptoms in patients with IBS-D and IBS-C: a pilot study

PloS one, 2013-12, Vol.8 (12), p.e85073-e85073

2013

Link zum Volltext

Verfügbarkeit prüfen

Endocannabinoid Metabolome Characterization of Transitional and Mature Human Milk

Nutrients, 2018-09, Vol.10 (9), p.1294

2018

Link zum Volltext

Verfügbarkeit prüfen

A comparison of novel, selective fatty acid amide hydrolase (FAAH), monoacyglycerol lipase (MAGL) or dual FAAH/MAGL inhibitors to suppress acute and anticipatory nausea in rat models

Psychopharmacology, 2016-06, Vol.233 (12), p.2265-2275

2016

Link zum Volltext

Verfügbarkeit prüfen

A neutral CB1 receptor antagonist reduces weight gain in rat

American journal of physiology. Regulatory, integrative and comparative physiology, 2007-12, Vol.293 (6), p.R2185-R2193

2007

Link zum Volltext

Verfügbarkeit prüfen

Endocannabinoid enhancement protects against kainic acid-induced seizures and associated brain damage

The Journal of pharmacology and experimental therapeutics, 2007-09, Vol.322 (3), p.1059

2007

Link zum Volltext

Verfügbarkeit prüfen

Equipotent Inhibition of Fatty Acid Amide Hydrolase and Monoacylglycerol Lipase – Dual Targets of the Endocannabinoid System to Protect against Seizure Pathology

Neurotherapeutics, 2012-10, Vol.9 (4), p.801-813

2012

Link zum Volltext

Verfügbarkeit prüfen

Heteroadamantyl Cannabinoids

Journal of medicinal chemistry, 2010-08, Vol.53 (15), p.5656-5666

2010

Link zum Volltext

Verfügbarkeit prüfen

Endocannabinoid Metabolome Characterization of Milk from Guatemalan Women Living in the Western Highlands

Current developments in nutrition, 2019-06, Vol.3 (6), p.nzz018-nzz018, Article nzz018

2019

Link zum Volltext

Verfügbarkeit prüfen

A New Generation Fatty Acid Amide Hydrolase Inhibitor Protects Against Kainate-Induced Excitotoxicity

Journal of molecular neuroscience, 2011-03, Vol.43 (3), p.493-502

2011

Link zum Volltext

Verfügbarkeit prüfen

Comprehensive profiling of the human circulating endocannabinoid metabolome: clinical sampling and sample storage parameters

Clinical chemistry and laboratory medicine, 2008-09, Vol.46 (9), p.1289-1295

2008

Link zum Volltext

Verfügbarkeit prüfen

Endocannabinoids are expressed in bone marrow stromal niches and play a role in interactions of hematopoietic stem and progenitor cells with the bone marrow microenvironment

The Journal of biological chemistry, 2011-07, Vol.286 (27), p.24534-24534

2011

Link zum Volltext

Verfügbarkeit prüfen

Suppression of food intake and food-reinforced behavior produced by the novel CB1 receptor antagonist/inverse agonist AM 1387

Pharmacology, biochemistry and behavior, 2006-03, Vol.83 (3), p.396-402

2006

Link zum Volltext

Verfügbarkeit prüfen

Conformationally constrained analogues of 2-arachidonoylglycerol

Bioorganic & medicinal chemistry letters, 2007-11, Vol.17 (21), p.5959-5963

2007

Link zum Volltext

Verfügbarkeit prüfen

Erratum: The Novel Cannabinoid CB1 Receptor Neutral Antagonist Am4113 Suppresses Food Intake and Food-Reinforced Behavior but Does not Induce Signs of Nausea in Rats

Neuropsychopharmacology (New York, N.Y.), 2008-05, Vol.33 (7), p.1776-1776

2008

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 35

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(35)
Mit Volltextzugriff
(33)

Publikationsform

Artikel
(35)

Sprache

Englisch
(35)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

Science & Technology
(31)
Life Sciences & Biomedicine
(27)
Pharmacology & Pharmacy
(16)
Animals
(15)
Endocannabinoids
(11)
Humans
(10)
Rats
(10)
Male
(9)
Neurosciences
(8)
Neurosciences & Neurology
(8)
Biochemistry & Molecular Biology
(7)
Chemistry, Medicinal
(7)
Rats, Sprague-Dawley
(7)
Biological And Medical Sciences
(6)
Fatty Acids
(6)
Female
(6)
Mice
(6)
Amidohydrolases - Antagonists & Inhibitors
(5)
Anandamide
(5)
Chemistry
(5)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Pharmacological characterization of AM1710, a putative cannabinoid CB2 agonist from the cannabilactone class: Antinociception without central nervous system side-effects

The novel cannabinoid CB1 receptor neutral antagonist AM4113 suppresses food intake and food-reinforced behavior but does not induce signs of nausea in rats

Endocannabinoids Are Expressed in Bone Marrow Stromal Niches and Play a Role in Interactions of Hematopoietic Stem and Progenitor Cells with the Bone Marrow Microenvironment

The Novel Cannabinoid CB1 Receptor Neutral Antagonist Am4113 Suppresses Food Intake and Food-Reinforced Behavior but Does not Induce Signs of Nausea in Rats

Inhibition of N-acylethanolamine acid amidase reduces nicotine-induced dopamine activation and reward

Improved cyclobutyl nabilone analogs as potent CB1 receptor agonists

Dietary docosahexaenoic acid supplementation alters select physiological endocannabinoid-system metabolites in brain and plasma

Piperidine and piperazine inhibitors of fatty acid amide hydrolase targeting excitotoxic pathology

Maternal Dietary Fatty Acids and Their Relationship to Derived Endocannabinoids in Human Milk

Oximes short-acting CB1 receptor agonists

Pharmacological characterization of AM1710, a putative cannabinoid CB 2 agonist from the cannabilactone class: Antinociception without central nervous system side-effects

Endocannabinoid and cannabinoid-like fatty acid amide levels correlate with pain-related symptoms in patients with IBS-D and IBS-C: a pilot study

Endocannabinoid Metabolome Characterization of Transitional and Mature Human Milk

A comparison of novel, selective fatty acid amide hydrolase (FAAH), monoacyglycerol lipase (MAGL) or dual FAAH/MAGL inhibitors to suppress acute and anticipatory nausea in rat models

A neutral CB1 receptor antagonist reduces weight gain in rat

Endocannabinoid enhancement protects against kainic acid-induced seizures and associated brain damage

Equipotent Inhibition of Fatty Acid Amide Hydrolase and Monoacylglycerol Lipase – Dual Targets of the Endocannabinoid System to Protect against Seizure Pathology

Heteroadamantyl Cannabinoids

Endocannabinoid Metabolome Characterization of Milk from Guatemalan Women Living in the Western Highlands

A New Generation Fatty Acid Amide Hydrolase Inhibitor Protects Against Kainate-Induced Excitotoxicity

Comprehensive profiling of the human circulating endocannabinoid metabolome: clinical sampling and sample storage parameters

Endocannabinoids are expressed in bone marrow stromal niches and play a role in interactions of hematopoietic stem and progenitor cells with the bone marrow microenvironment

Suppression of food intake and food-reinforced behavior produced by the novel CB1 receptor antagonist/inverse agonist AM 1387

Conformationally constrained analogues of 2-arachidonoylglycerol

Erratum: The Novel Cannabinoid CB1 Receptor Neutral Antagonist Am4113 Suppresses Food Intake and Food-Reinforced Behavior but Does not Induce Signs of Nausea in Rats

Suchergebnisse filtern